PLSE Pulse Biosciences Inc

$PLSE rides the 10DMA beautifully even in the worst market of all time that pricing in a hike. BULLISH AF

$PLSE The cynic in me says the short-side "research" groups are out right now to drive the price down for investors wishing to buy into the new ATM (issued yesterday) at a reduced price.

$PLSE dumpster fire 🔥 rats will jump ship 🚢 total rat boat loaded with rodents MACK here to EXTERMINATE the rats

Freedom Capital Markets analyst Keith Hinton initiated coverage of Pulse Biosciences with a Buy rating and a $73 price target, sparking renewed investor interest in the bioelectric medicine company. The target implies substantial upside from current levels and comes as the stock approaches its 52-week high of $58.90, after rising sharply from its 52-week low of $12.56. Hinton’s bullish thesis centers on the atrial fibrillation ablation market, which he views as large, growing and ripe for disruption by Pulse Biosciences’ proprietary nanosecond pulsed field ablation (nsPFA) technology. Freedom also highlighted the company’s strong balance sheet and strategic positioning, which it believes provide sufficient financial support to reach the next major clinical data catalyst. A key part of the thesis is the NANOPULSE-AF trial, with results expected around the second quarter of 2027. $PLSE

$PLSE Checked MAXPAIN calculator. For PLSE options expiring Sep 18 = $50. It will probably be pinned here until then.

$PLSE Please try harder WhiteResearch missed the COO’s open-market buys around $48–50 while calling disclosed analyst meetings a secret dump. Duggan and the CEO haven’t bought above the May $19.69 prints—that part holds. No one on his list is even looking to short it. Your sorry attempt to mislead spread false information is sad - and on top of that you're the same clowns that tried this last time with false information lol